Skin Cancer Treatment Market is anticipated to Surpass $14.5 Billion by 2031 – Rise in prevalence of skin cancer cases

Rise in the prevalence of melanoma and non-melanoma skin cancer, increase in the number of product launch for skin cancer treatment and rise in awareness among people regarding skin cancer.

14 Reasons You Can Blame the Recession on Oncology/cancer Drugs Market

Furthermore, the global oncology/cancer drugs market growth is propelled by surge in geriatric population, increase in collaboration between pharmaceutical companies for development of novel cancer drugs, and rise in awareness associated with early detection of cancer among populace.

Oncology/Cancer Drugs Market Expected to reach $274.40 Billion by 2030 | By Allied Market Research

North America accounted for the largest share of revenue in 2020, and is anticipated to maintain its dominance from 2021 to 2030, owing to presence of large patient population, strong presence of key players, ease of drug availability.

Oncology-Cancer Drugs Market | Industry, Revenue & Trends Analysis From 2021 To 2030

The global oncology drugs market size was valued at $135,494.17 million in 2020, and is projected to reach $274,400.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.